GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » YoY EPS Growth

Alkem Laboratories (NSE:ALKEM) YoY EPS Growth : 30.84% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Alkem Laboratories's YoY EPS Growth for the quarter that ended in Dec. 2023 was 30.84%.

Alkem Laboratories's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ₹49.76.


Alkem Laboratories YoY EPS Growth Historical Data

The historical data trend for Alkem Laboratories's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories YoY EPS Growth Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.54 48.18 40.64 3.82 -40.19

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.49 -34.04 124.53 87.57 30.84

Alkem Laboratories YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Alkem Laboratories's YoY EPS Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EPS Growth (A: Mar. 2023 )
=(Earnings per Share (Diluted) (A: Mar. 2023 )-Earnings per Share (Diluted) (A: Mar. 2022 ))/ | Earnings per Share (Diluted) (A: Mar. 2022 ) |
=(82.31-137.63)/ | 137.63 |
=-40.19 %

Alkem Laboratories's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(49.76-38.03)/ | 38.03 |
=30.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkem Laboratories YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines